BIR “TAX VARIANT” THREATENS HEALTHCARE SUPPLY MANUFACTURERS

NATION
By ALY ABELLANA
July 24, 2021

SHARE

Senator Imee Marcos has sought to protect local manufacturers of personal protective equipment (PPE), surgical masks, and other medical supplies from a “tax variant” that the Bureau of Internal Revenue (BIR) released in June.

Marcos was referring to BIR regulation 9-2021 canceling a 12% value added tax (VAT) exemption that used to lower the costs of raw materials, packaging supplies and other services for exporters including makers of critical healthcare supplies.

“This mutation of tax regulation threatens to cancel gains some exporters have already made toward economic recovery and will push them back into a critical state,” Marcos said.

Marcos, who chairs the Senate committee on economic affairs, cited the case of garments exporters who have been coping with the Covid-19 pandemic’s economic onslaught by shifting their production from ready-to-wear to PPE, lab gowns, and surgical masks.

However, Marcos said that their meager profits averaging less than 5% may be wiped out by the new BIR regulation imposing the 12% VAT.

For more than a year now, Marcos has been advocating tax exemptions for local makers of critical healthcare products during a health emergency, as proposed in Senate Bill 1708 or the “Healthcare Manufacturing and Pandemic Protection Act.”

The bill will not only attract foreign investors but also preserve local jobs, Marcos said.

“During health emergencies, local sales of critical healthcare goods produced by exporters will be treated as export sales. So, these will be exempted from VAT, duties and fees, with export incentives kept intact,” Marcos explained.

If demand during a health emergency so requires, manufacturers in special economic zones can devote as much as 80% of their production to local sales which will be credited to their export sale requirements under government rules.

The Marcos bill also mandates the government to procure healthcare supplies from local manufacturers first, as long as their bid prices do not exceed a foreign bidder’s lowest price by 25%.

“The Department of Health could have avoided the controversy over allegedly overpriced PPEs amounting to Php1.8 billion, had it procured from local manufacturers who can produce the same goods for a much cheaper price,” Marcos said.

 


RELATED ARTICLES

LEAVE A REPLY

Subscribe Now!

Receive email updates from Mindanao Daily News.